Paul C Grint - Net Worth and Insider Trading
Paul C Grint Net Worth
The estimated net worth of Paul C Grint is at least $620,004 dollars as of 2024-11-13. Paul C Grint is the Director of Illumina Inc and owns about 4,200 shares of Illumina Inc (ILMN) stock worth over $620,004. Details can be seen in Paul C Grint's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul C Grint has not made any transactions after 2010-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul C Grint
Paul C Grint Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul C Grint owns 4 companies in total, including Armata Pharmaceuticals Inc (ARMP) , Regulus Therapeutics Inc (RGLS) , and Illumina Inc (ILMN) among others .
Click here to see the complete history of Paul C Grint’s form 4 insider trades.
Insider Ownership Summary of Paul C Grint
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARMP | Armata Pharmaceuticals Inc | 2015-11-05 | director |
RGLS | Regulus Therapeutics Inc | 2014-06-16 | Chief Medical Officer |
ILMN | Illumina Inc | 2010-10-27 | director |
2023-06-30 | director |
Paul C Grint Latest Holdings Summary
Paul C Grint currently owns a total of 1 stock. Paul C Grint owns 4,200 shares of Illumina Inc (ILMN) as of October 27, 2010, with a value of $620,004.
Latest Holdings of Paul C Grint
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ILMN | Illumina Inc | 2010-10-27 | 4,200 | 147.62 | 620,004 |
Holding Weightings of Paul C Grint
Paul C Grint Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul C Grint has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 10,000 shares on October 27, 2010, which brought Paul C Grint around $558,100.
Insider Trading History of Paul C Grint
- 1
Paul C Grint Trading Performance
Paul C Grint Ownership Network
Ownership Network List of Paul C Grint
Ownership Network Relation of Paul C Grint
Paul C Grint Owned Company Details
What does Armata Pharmaceuticals Inc do?
Who are the key executives at Armata Pharmaceuticals Inc?
Paul C Grint is the director of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .
Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Armata Pharmaceuticals Inc Insider Transactions
Paul C Grint Mailing Address
Above is the net worth, insider trading, and ownership report for Paul C Grint. You might contact Paul C Grint via mailing address: 7757 Doughill Court, San Diego Ca 92127.